Clinical Trials Browser

Phase 2 × Gallbladder Neoplasms × durvalumab × Clear all

NCT05712356 2025-06-06

BOLSTER

Phase 2 Active not recruiting

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT03473574 2023-06-15

IMMUCHEC

Phase 2 Completed

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma